2016 annual financial data

Nektar Therapeutics 2016 Financial results

Direct answer

Revenue was 165,436,000 USD.

Operating income was -112,855,000 USD and net income was -153,524,000 USD.
Operating cash flow was -117,024,000 USD.

Get free Nektar Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
165,436,000 USD
Operating income
-112,855,000 USD
Net income
-153,524,000 USD
Operating cash flow
-117,024,000 USD